Foresite Capital Management IV, LLC

SEC Form 4 insider trading activity

Foresite Capital Management IV, LLC has filed 1 SEC Form 4 filing (15 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 6, 2026.

On the most recent filing, Foresite Capital Management IV, LLC is listed as 10% Owner at Eikon Therapeutics, Inc. Inside the rolling window, Foresite Capital Management IV, LLC reported 1 open-market purchase totaling $1000K in EIKN and no open-market sales.

Companies traded

Other insiders at EIKN

Insider Buying

$1000K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
EIKN
Foresite Capital Management IV, LLC
Purchase$1000KFeb 6SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Foresite Capital Management IV, LLC made?

Foresite Capital Management IV, LLC has filed 1 SEC Form 4 filing (15 transaction rows) across 1 company since 2026.

Which companies does Foresite Capital Management IV, LLC trade?

Foresite Capital Management IV, LLC has filed SEC Form 4 disclosures for 1 company, including EIKN.

When was Foresite Capital Management IV, LLC's most recent SEC Form 4 filing?

Foresite Capital Management IV, LLC's most recent SEC Form 4 filing on Tracefour is dated Feb 6, 2026.

What is Foresite Capital Management IV, LLC's total buy and sell value in the current window?

Inside the rolling retention window, Foresite Capital Management IV, LLC bought $1000K and sold $0 based on SEC Form 4 filings.

What was Foresite Capital Management IV, LLC's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 55,555 EIKN shares on 2026-02-04, worth $1000K, per SEC Form 4 filings.